TCL Archive ASCO Annual Report Names Significant Clinical Research Advances Of Past Year December 25, 2009
TCL Archive ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention January 10, 1997
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
